Overall Survival in 7/8 HLA-Matched Hematopoietic Stem Cell Transplantation Patients Treated With Abatacept Combined With a Calcineurin Inhibitor and Methotrexate- An Analysis of the Center for International Blood and Marrow Transplant Research (CIBMTR) Database
Latest Information Update: 21 Jun 2022
At a glance
- Drugs Abatacept (Primary)
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- Sponsors Bristol-Myers Squibb
Most Recent Events
- 21 Jun 2022 New trial record